StonvexLoading…
StonvexStonvexStonvexCore line items from CTOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $328.60M | $1.45B | $1.06B | $699.26M |
Operating Income | $31.47M | $124.94M | $72.97M | $40.34M |
Net Income | $-4.10M | $-31.05M | $-51.93M | $-28.38M |
EPS (Diluted) | $-0.02 | $-0.14 | $-0.23 | $-0.20 |
Total Assets | $3.55B | $3.44B | $3.54B | $3.58B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.61M | $6.27M | $13.06M | $5.26M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 226.78M | 226.63M | 226.56M | 226.56M |